“…In rodents, NO donors evoke elevated CGRP blood levels, meningeal inflammation, photo and phonophobia, sensitization of central neurons of the trigeminal nucleus caudalis (TNC), cephalic and extra‐cephalic allodynia, as well as spontaneous facial pain. The effectiveness of clinically relevant treatments like sumatriptan, CGRP antagonists and antibodies, anti‐inflammatory drugs, or prophylactic drugs like propranolol and topiramate further support the relevance of these animal models of migraine (Bates et al ., ; Jansen‐Olesen et al ., ; Pradhan et al ., ; Farkas et al ., ; Goadsby et al ., ; Harris et al ., ; Schytz et al ., ). Effects of systemic ISDN injections were recently described in rats, with a facilitation of C‐fibre‐evoked responses in 50% of second‐order central neurons (Flores Ramos et al ., ; Dallel et al ., ), leading to cutaneous pain sensitization.…”